Dupilumab Decreases Blood Biomarkers in Adolescents With Moderate-to-Severe Atopic Dermatitis: Data From a Phase 3 Trial (LIBERTY AD ADOL). J of Skin [Internet]. 2020 Sep. 2 [cited 2025 Apr. 19];4(5):s49. Available from: https://skin.dermsquared.com/skin/article/view/1007